Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:13:22 EST Mon 09 Feb 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  0.22.74·2.891.22.8449.31291502.84  2.85  2.783.90  1.96Feb 06Feb 0315 min RT 2¢
TSX - T0.22.74·2.891.22.8432.485792.83  2.85  2.793.90  1.96Feb 0615 min
NEO ATS - U 2.80-0.04-1.42.2682.82  2.85  2.79Feb 0615 min
Alpha - A 2.80-0.04-1.41.6472.79  2.83  2.79Feb 0615 min
CSE ATS - P 2.81-0.03-1.14.913142.84  2.84  2.79Feb 0615 min
CXC - X 2.85+0.010.40.5122.84  2.85  2.84Feb 0615 min
CX2 - H 2.79-0.05-1.80.4132.80  2.80  2.79Feb 0615 min
CXD - D 2.80-0.04-1.40.4162.82  2.82  2.79Feb 0615 min
MatchNOW - M 2.842.4616    Sep 11/2015 min
Lynx - Y 2.83-0.01-0.44.411152.84  2.85  2.78Feb 0615 min

Recent Trades - Last 10 of 150
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-02-03 17:31C:MDP2.89News ReleaseMedexus Schedules Third Fiscal Quarter 2026 Conference Call
2025-11-20 16:39C:MDP2.61News ReleaseMedexus arranges NCIB to buy back up to 10% of float
2025-11-17 18:35C:MDP2.70News ReleaseMedexus obtains $51-million (U.S.) credit, plans NCIB
2025-11-12 18:18C:MDP2.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-12 18:18C:MDP2.70SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-12 18:07C:MDP2.70News ReleaseMedexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
2025-11-05 00:49C:MDP2.69News ReleaseMedexus Pharmaceuticals to release Q2 results Nov. 12
2025-09-26 04:40C:MDP2.97News ReleaseMedexus shareholders approve all proposals at AGM
2025-08-12 17:44C:MDP2.75SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-12 17:38C:MDP2.75SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-12 17:30C:MDP2.75News ReleaseMedexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection
2025-08-05 17:31C:MDP2.89News ReleaseMedexus Schedules First Fiscal Quarter 2026 Conference Call
2025-08-05 17:30C:MDP2.89News ReleaseMedexus's Grafapex add-on payment okayed by Medicare
2025-06-25 18:40C:MDP3.35SEDAR MD & ASEDAR MD & A
2025-06-25 18:40C:MDP3.35SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-25 18:29C:MDP3.35SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 18:16C:MDP3.35News ReleaseMedexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States
2025-06-17 20:20C:MDP3.03News ReleaseMedexus to file fiscal 2025 results June 25
2025-04-17 16:34C:MDP2.55News ReleaseMedexus completes listing agreement for Trecondyv
2025-04-07 16:19C:MDP2.17News ReleaseMedexus talks up market response to Grafapex